Halozyme Therapeutics | HALO - Trade Debtors

Stock Price
81.23
Daily Change
2.81 3.58%
Monthly
8.15%
Yearly
42.26%
Q1 Forecast
69.50

Halozyme Therapeutics reported $346.04M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Acadia Pharmaceuticals USD 139.44M 19.75M Sep/2025
Agios Pharmaceuticals USD 5.03M 43K Sep/2025
Alnylam Pharmaceuticals USD 964.77M 397.66M Sep/2025
Amarin USD 127.31M 8.18M Sep/2025
Amgen USD 8.49B 211M Sep/2025
Baxter International USD 1.77B 127M Jun/2025
Cytokinetics USD 1.81M 6.6M Sep/2025
DBV Technologies USD 15.97M 279K Sep/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Halozyme Therapeutics USD 346.04M 29.7M Sep/2025
Ionis Pharmaceuticals USD 24.61M 27.97M Sep/2025
MannKind USD 17.38M 9.76M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
United Therapeutics USD 297.7M 81.6M Sep/2025